The ROE as of December 2025 (TTM) for Mayne Pharma Group Limited (MAYNF) is -22.99%

According to Mayne Pharma Group Limited’s latest financial reports and current stock price. The company's current ROE is -22.99%. This represents a change of 53.55% compared to the average of -14.97% of the last 4 quarters.

Mayne Pharma Group Limited (MAYNF) Historical ROE (quarterly & annually)

How has MAYNF ROE performed in the past?

The mean historical ROE of Mayne Pharma Group Limited over the last ten years is -15.44%. The current -22.99% ROE has changed 48.87% with respect to the historical average. Over the past ten years (40 quarters), MAYNF's ROE was at its highest in in the June 2012 quarter at 10.05%. The ROE was at its lowest in in the June 2022 quarter at -37.71%.

Mayne Pharma Group Limited (MAYNF) ROE by Quarter and Year

Discovering the peaks and valleys of Mayne Pharma Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mayne Pharma Group Limited (MAYNF) Average ROE

How has MAYNF ROE performed in the past?

The current ROE of Mayne Pharma Group Limited (MAYNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Mayne Pharma Group Limited (MAYNF) ROE vs. Peers

How is MAYNF’s ROE compared to its peers?

Mayne Pharma Group Limited’s ROE is less than Benchmark Holdings plc (18.62%), greater than Silence Therapeutics plc (-85.88%), greater than Transgene S.A. (-634.16%), less than Hansa Biopharma AB (publ) (115.70%), less than Cipher Pharmaceuticals Inc. (11.68%), less than American Oncology Network, Inc. (235.23%), less than China Evergrande New Energy Vehicle Group Limited (20.82%), less than Orpea S.A. (703.78%), greater than Craftport Cannabis Corp. (-194.22%), less than Tristel PLC (19.22%),

Build a custom stock screener for Mayne Pharma Group Limited (MAYNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mayne Pharma Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mayne Pharma Group Limited (MAYNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mayne Pharma Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.